Health Care
Drug Pricing
Wayne Winegarden Discusses Drug Price controls on Jim Bohannon Show
Wayne Winegarden, Director for PRI’s Center for Medical Economics and Innovation, discusses the many problems with drug price controls on the nationally syndicated Jim Bohannon Show.
Wayne Winegarden
November 13, 2019
Health Care
Sally Pipes Quoted in the Daily Wire
As the 2020 election looms closer, health care has choked out virtually every other issue to stand alone as the primary focus of several top-tier candidates in the Democratic primary race. . . . . .Sally Pipes, the president and CEO of the Pacific Research Institute in California, is Canadian. ...
Pacific Research Institute
November 11, 2019
Commentary
A dose of reality on Medicare for All’s cost
Presidential hopeful Elizabeth Warren just released her plan to pay for Medicare for All. It’s ludicrous from the jump. For starters, its price tag is “only” $20.5 trillion in new federal spending over 10 years. That’s $10 trillion less than both the libertarian Mercatus Center and the left-leaning Urban Institute estimate Medicare for All’s cost to ...
Sally C. Pipes
November 11, 2019
Commentary
There Are High Costs From Implementing Drug Price Controls
Once wide coercive powers are given to government agencies…such powers cannot be effectively controlled. F.A. Hayek As part of the chorus calling for drug price controls, the New York Times editorial page has claimed that “Americans will need to accept a trade-off that other advanced nations long since come around to: Slightly ...
Wayne Winegarden
November 7, 2019
Commentary
No, There’s No Wild Bee-pocalypse, Either!
Did you catch the story about the swarm of 25,000 bees that had to be captured and removed (by a special police unit, no less) from the Staten Island Ferry Station in New York City? After many years of media reports about honeybees and wild bees dying off, you’d think ...
Henry Miller, M.S., M.D.
November 7, 2019
Agriculture
Tales of Woe: How Dysfunctional Regulation Has Decimated Entire Sectors of Biotechnology
“To observe government is to observe the absence of accountability,” James Freeman wrote in the Wall Street Journal.1 That’s certainly true of unwise regulation of many innovative technologies; and modern biotechnology, also known as “genetic engineering (GE)” or “genetic modification (GM),” perhaps along with civilian applications of nuclear power, could be ...
Henry Miller, M.S., M.D.
November 6, 2019
Commentary
TennCare block grant will serve as blueprint for the country
Tennessee has a plan to revolutionize health care for its low-income residents. The Volunteer State is petitioning the federal government to fund its Medicaid program, TennCare, with an annual lump-sum payment. The Medicaid funding status quo, wherein the federal government matches every dollar a state spends on the program, encourages ...
Sally C. Pipes
November 6, 2019
Commentary
Warren’s ‘Medicare-for-all’ is financial fantasy – There’s no way to do this fuzzy math
Sen. Elizabeth Warren, D-Mass., has released her plan for financing “Medicare-for-all.” She claims it’ll cost “just” $20.5 trillion in new federal spending over 10 years, with, in her words, “not one penny in middle-class tax increases.” Warren has little choice but to indulge in fuzzy math. After all, doubling everyone’s ...
Sally C. Pipes
November 4, 2019
Drug Pricing
Wayne Winegarden Discusses Drug Price Controls on Lars Larson Show
Listen to Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss his recent Forbes op-ed on prescription drug price controls and how they would threaten access to innovative cures for America’s patients on “The Lars Larson Show.”
Pacific Research Institute
November 1, 2019
Featured
Watch Sally Pipes on Fox Business: How Much Would a Single-Payer Plan Cost?
PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes discusses 2020 Democratic contender Sen. Elizabeth Warren’s plan to provide a public health care system with host Elizabeth MacDonald on “The Evening Edit” on Fox Business. Pipes makes the case that the Warren plan would ...
Pacific Research Institute
October 31, 2019
Wayne Winegarden Discusses Drug Price controls on Jim Bohannon Show
Wayne Winegarden, Director for PRI’s Center for Medical Economics and Innovation, discusses the many problems with drug price controls on the nationally syndicated Jim Bohannon Show.
Sally Pipes Quoted in the Daily Wire
As the 2020 election looms closer, health care has choked out virtually every other issue to stand alone as the primary focus of several top-tier candidates in the Democratic primary race. . . . . .Sally Pipes, the president and CEO of the Pacific Research Institute in California, is Canadian. ...
A dose of reality on Medicare for All’s cost
Presidential hopeful Elizabeth Warren just released her plan to pay for Medicare for All. It’s ludicrous from the jump. For starters, its price tag is “only” $20.5 trillion in new federal spending over 10 years. That’s $10 trillion less than both the libertarian Mercatus Center and the left-leaning Urban Institute estimate Medicare for All’s cost to ...
There Are High Costs From Implementing Drug Price Controls
Once wide coercive powers are given to government agencies…such powers cannot be effectively controlled. F.A. Hayek As part of the chorus calling for drug price controls, the New York Times editorial page has claimed that “Americans will need to accept a trade-off that other advanced nations long since come around to: Slightly ...
No, There’s No Wild Bee-pocalypse, Either!
Did you catch the story about the swarm of 25,000 bees that had to be captured and removed (by a special police unit, no less) from the Staten Island Ferry Station in New York City? After many years of media reports about honeybees and wild bees dying off, you’d think ...
Tales of Woe: How Dysfunctional Regulation Has Decimated Entire Sectors of Biotechnology
“To observe government is to observe the absence of accountability,” James Freeman wrote in the Wall Street Journal.1 That’s certainly true of unwise regulation of many innovative technologies; and modern biotechnology, also known as “genetic engineering (GE)” or “genetic modification (GM),” perhaps along with civilian applications of nuclear power, could be ...
TennCare block grant will serve as blueprint for the country
Tennessee has a plan to revolutionize health care for its low-income residents. The Volunteer State is petitioning the federal government to fund its Medicaid program, TennCare, with an annual lump-sum payment. The Medicaid funding status quo, wherein the federal government matches every dollar a state spends on the program, encourages ...
Warren’s ‘Medicare-for-all’ is financial fantasy – There’s no way to do this fuzzy math
Sen. Elizabeth Warren, D-Mass., has released her plan for financing “Medicare-for-all.” She claims it’ll cost “just” $20.5 trillion in new federal spending over 10 years, with, in her words, “not one penny in middle-class tax increases.” Warren has little choice but to indulge in fuzzy math. After all, doubling everyone’s ...
Wayne Winegarden Discusses Drug Price Controls on Lars Larson Show
Listen to Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss his recent Forbes op-ed on prescription drug price controls and how they would threaten access to innovative cures for America’s patients on “The Lars Larson Show.”
Watch Sally Pipes on Fox Business: How Much Would a Single-Payer Plan Cost?
PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes discusses 2020 Democratic contender Sen. Elizabeth Warren’s plan to provide a public health care system with host Elizabeth MacDonald on “The Evening Edit” on Fox Business. Pipes makes the case that the Warren plan would ...